Breast cancer clinical trials have resulted in breakthrough treatments to reduce the incidence of the disease or slow its progression, but few cancer patients participate in trials, often because of fears and misconceptions, medical experts said.“Only 3 to 5 percent of adult eligible cancer patients participate in trials. That is a major barrier to advancing knowledge about breast cancer ...